Economic Evaluation of Pharmacy Services
Autor: | Zaheer-Ud-Din Babar |
---|---|
EAN: | 9780128037003 |
eBook Format: | PDF/ePUB |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 15.10.2016 |
Kategorie: | |
Schlagworte: | Africa Anti-coagulation Application to pharmacy services A proposal Asia Community Community pharmacy Community pharmacy setting Copolymers Cost-effectiveness Cost-effectiveness analysis Cost-mi Cost-minimization Cost effectiveness model |
57,95 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Economic Evaluation of Pharmacy Services provides the latest on the trend to a more product-centered and service-centered practice, eschewing traditional economic evaluation techniques that focus on product-to-product comparisons in favor of evaluating processes that measure costs and health outcomes. Complete with examples focusing on best practices, including various study designs, types of pharmacy services, and types of outcomes being evaluated, the book emphasizes case studies and examples that help readers understand economic evaluation techniques. Many of these techniques are transferable across countries, especially where there are advanced and stable health systems in place. With the help of this practical guide, readers will gain a thorough understanding of the application of economic evaluation of pharmacy services. - Delivers a practical guide for conducting economic evaluations of hospital and community pharmacy services - Documents the literature around health economic evaluation and innovative pharmacy services - Guides the development of a standardized health economic evaluation tool to evaluate these services
With over 25 years of experience in pharmaceutical policy and practice research, Prof Zaheer Babar is a global authority and a prolific author in this field. He comes with a long-standing academic career in pharmacy in New Zealand, and the United Kingdom. He is globally known for his work in policy and practice, including quality use of medicines, and issues related to medicines access and pricing. Prof. Babar has published over 300 papers and is considered the leading researcher in the 'pharmacy practice research category”. He has published in high-impact journals such as PLoS Medicine and the Lancet and has acted as a consultant for the WHO, RPS, UNDP, HAI, MSH, FIP, International Union Against Tuberculosis and Lung Disease, World Bank, European Union, and the Pharmaceutical Management Agency of New Zealand. His edited work includes 'Economic Evaluation of Pharmacy Services', 'Pharmaceutical Prices in the 21st Century', 'Pharmaceutical Policies in Countries with Developing Healthcare Systems', 'Global Pharmaceutical Policy', 'Access to high-cost medicines', 'Pharmacy Practice Research Methods', 'Pharmacy Practice Research Case Studies' , 'Encyclopaedia of Pharmacy Practice and Clinical Pharmacy', and 'Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy'. Published by Elsevier and Adis/Springer, his work is used in curriculum design, policy development, and referral all around the globe. Professor Babar is the founding Editor-In-Chief of the Journal of Pharmaceutical Policy and Practice [IF = 4.2], a high-impact publication that provides evidence-based insights and recommendations for policymakers, practitioners, and researchers. He can be contacted at: z.babar@hud.ac.uk
With over 25 years of experience in pharmaceutical policy and practice research, Prof Zaheer Babar is a global authority and a prolific author in this field. He comes with a long-standing academic career in pharmacy in New Zealand, and the United Kingdom. He is globally known for his work in policy and practice, including quality use of medicines, and issues related to medicines access and pricing. Prof. Babar has published over 300 papers and is considered the leading researcher in the 'pharmacy practice research category”. He has published in high-impact journals such as PLoS Medicine and the Lancet and has acted as a consultant for the WHO, RPS, UNDP, HAI, MSH, FIP, International Union Against Tuberculosis and Lung Disease, World Bank, European Union, and the Pharmaceutical Management Agency of New Zealand. His edited work includes 'Economic Evaluation of Pharmacy Services', 'Pharmaceutical Prices in the 21st Century', 'Pharmaceutical Policies in Countries with Developing Healthcare Systems', 'Global Pharmaceutical Policy', 'Access to high-cost medicines', 'Pharmacy Practice Research Methods', 'Pharmacy Practice Research Case Studies' , 'Encyclopaedia of Pharmacy Practice and Clinical Pharmacy', and 'Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy'. Published by Elsevier and Adis/Springer, his work is used in curriculum design, policy development, and referral all around the globe. Professor Babar is the founding Editor-In-Chief of the Journal of Pharmaceutical Policy and Practice [IF = 4.2], a high-impact publication that provides evidence-based insights and recommendations for policymakers, practitioners, and researchers. He can be contacted at: z.babar@hud.ac.uk